IDXXIdexx Laboratories
$675.90+7.5% 1Y
$675.90
$504.5952 weeks$766.68
Growth
Is IDXX growing?
Idexx Laboratories's revenue has grown 9.1% a year over three years, and grown 8.3% a year over five, with earnings per share compounding at 15%.
+9.1%
Revenue growth, 3-year annual rate · Diagnostics & Research median +9.4% · compounded from trailing twelve-month revenue
- Revenue growth, 5-year rate
- +8.3%
Revenue growth, 5-year rate · +9.1% over three · the three-year rate is above the five-year rate
- Earnings per share, 3-year rate
- +15%
Earnings per share, 3-year rate · revenue +9.1% · earnings per share grew faster than revenue
- Years of annual history on file
- 18
Years of annual history on file · FY2008 to FY2025, as filed
Details›
- Revenue FY2021
- $3.22B
- Revenue FY2022
- $3.37B
- Revenue FY2023
- $3.66B
- Revenue FY2024
- $3.90B
- Revenue FY2025
- $4.30B
Annual income statements as filed with the SEC.
Where the revenue comes from
14 quarters, Mar 2023 to Jun 2026Vet Lab Consumables, quarter to Jun 2026from $291.1M in Mar 2023$430.3M
Vet Lab Consumables$430.3M
Reference Laboratory Diagnostic And Consulting Services$406.7M
Rapid Assay Products$101.6M
Veterinary Software Services And Diagnostic Imaging Systems$96.3M
Recurring$76.3M
3 more segments$103.3M
Diagnostics & Research
The closest names by size in the same industry